Knight Therapeutics Inc. (TSX:GUD)

Canada · Delayed Price · Currency is CAD

6.41

+0.11 (1.75%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		371.30M	328.20M	293.56M	243.48M	199.52M
Pharmaceuticals Growth		13.13%	11.80%	20.57%	22.03%	320.39%
Total		371.30M	328.20M	293.56M	243.48M	199.52M
Total Growth		13.13%	11.80%	20.57%	22.03%	320.39%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Brazil		180.63M	168.22M	134.73M	97.20M	78.71M
Brazil Growth		7.38%	24.86%	38.60%	23.50%	242.78%
Canada		25.69M	19.67M	11.35M	7.70M	5.00M
Canada Growth		30.60%	73.39%	47.35%	54.15%	110.67%
Colombia		51.48M	44.63M	48.15M	43.52M	34.82M
Colombia Growth		15.34%	-7.30%	10.63%	25.00%	699.84%
Argentina		45.90M	24.10M	46.13M	42.96M	37.85M
Argentina Growth		90.48%	-47.76%	7.36%	13.51%	1085.68%
Mexico		18.99M	15.89M	-	-	-
Mexico Growth		19.52%	-	-	-	-
Rest of The Latin America		38.83M	39.22M	40.17M	40.95M	33.86M
Rest of The Latin America Growth		-1.00%	-2.37%	-1.89%	20.92%	891.89%
Other		9.78M	16.48M	13.05M	11.15M	9.29M
Other Growth		-40.62%	26.27%	17.07%	19.98%	-16.83%
Total		371.30M	328.20M	293.56M	243.48M	199.52M
Total Growth		13.13%	11.80%	20.57%	22.03%	320.39%

Source: S&P Global Market Intelligence.